Primary Article

Cushing's Disease Megadose Dexamethasone Suppression in a Case Refractory to Medical Therapy

Authors: LT SANFORD E. WARREN MC, USNR, LCDR DONALD K. WESTBIE MC, USNR, CDR RICHARD G. DALY MC, USNR, LCDR ROGER H. BOWER MC, USNR

Abstract

A patient with Cushing's disease failed to show complete suppressibility of adrenal function with conventional “high” doses of dexamethasone (8 mg per day). Higher doses were required to achieve suppression. Pituitary irradiation and medical therapy (cyproheptadine, metyrapone, and aminoglutethimide) failed to control the disease, necessitating bilateral adrenalectomy. The diagnostic and therapeutic implications of megadose dexamethasone suppression have not been clearly addressed in the medical literature. It is possible that adrenal suppression achieved only with unconventionally high doses of steroids may be predictive of refractoriness to nonsurgical therapy.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References